PGLYRP4 and susceptibility to pneumonia measurement: Because of this broad spectrum of known antibacterial activity, but unknown activity against S. pneumoniae, we investigated the in vivo effects of PGLYRP4 in a PGLYRP4-deficient mouse pneumonia model.